See how top analysts and institutions rate HL — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Roth Capital | Downgrade | Neutral → Sell | $8.75 | 2025-10-03 |
| Roth Capital | Downgrade | Buy → Neutral | $6 | 2025-07-01 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 2 | 4 | 1 | 0 |
| October 2025 | 2 | 2 | 5 | 0 | 0 |
| September 2025 | 2 | 2 | 5 | 0 | 0 |
| July 2025 | 2 | 3 | 5 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for HL, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
